A study reported that DNMT1 is involved in the promotion of hepatocellular carcinoma, while this process has been proven to be inhibited by miR-185 by targeting the DNMT1/PTEN/AKT pathway [42]. This evidence concerns the gene DNMT1 and hepatocellular carcinoma.